We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

86 hedge funds and large institutions have $416M invested in VanEck Pharmaceutical ETF in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,704% more call options, than puts

Call options by funds: $7.4M | Put options by funds: $410K

25% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 24

20% more capital invested

Capital invested by funds: $346M → $416M (+$69.7M)

12.76% more ownership

Funds ownership: 64.52% → 77.28% (+13%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 91 → 86 (-5)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
86
Holders Change
-5
Holders Change %
-5.49%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
30
Reduced
24
Closed
13
Calls
$7.4M
Puts
$410K
Net Calls
+$6.99M
Net Calls Change
+$3.31M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$128M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.53M
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$3.72M
4
TRCT
Tower Research Capital (TRC)
New York
+$3.46M
5
LPL Financial
LPL Financial
California
+$2.27M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$6.13M
2
Jane Street
Jane Street
New York
-$2.69M
3
M&T Bank
M&T Bank
New York
-$2.2M
4
LJAC
L.J. Altfest & Co
New York
-$836K
5
Bank of America
Bank of America
North Carolina
-$799K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$1.08M -$22.6K -307 -2%
RJA
27
Raymond James & Associates
Florida
$901K +$2.95K +40 +0.3%
BHB
28
Bank Hapoalim BM
Israel
$891K +$54.4K +739 +6%
Marshall Wace
29
Marshall Wace
United Kingdom
$848K +$540K +7,330 +139%
AWM
30
Axxcess Wealth Management
California
$805K -$30.9K -420 -3%
Cohen & Steers
31
Cohen & Steers
New York
$790K +$139K +1,893 +19%
RFWA
32
RPg Family Wealth Advisory
Massachusetts
$779K – – –
PPG
33
Peak Planning Group
Colorado
$686K +$58.9K +799 +9%
Osaic Holdings
34
Osaic Holdings
Arizona
$548K +$393K +5,341 +190%
Walleye Capital
35
Walleye Capital
New York
$479K +$525K +7,127 New
TWM
36
Tradition Wealth Management
Minnesota
$445K -$41K -556 -8%
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
$358K +$178K +2,416 +83%
LSPW
38
Lake Street Private Wealth
Illinois
$352K +$31K +421 +9%
RAM
39
Riggs Asset Management
Pennsylvania
$347K +$2.21K +30 +0.6%
SWM
40
SeaCrest Wealth Management
New York
$328K +$341K +4,623 +1,849%
Wells Fargo
41
Wells Fargo
California
$315K – – –
TSS
42
Two Sigma Securities
New York
$290K +$318K +4,319 New
JMPWA
43
JP Morgan Private Wealth Advisors
California
$289K -$21.2K -288 -6%
EDRH
44
Edmond de Rothschild Holding
Switzerland
$285K -$153K -2,073 -33%
MML Investors Services
45
MML Investors Services
Massachusetts
$273K +$299K +4,063 New
Envestnet Asset Management
46
Envestnet Asset Management
Illinois
$272K +$298K +4,039 New
WSCM
47
Wellington Shields Capital Management
New York
$269K +$295K +4,000 New
Neuberger Berman Group
48
Neuberger Berman Group
New York
$248K +$273K +3,703 New
KIA
49
KCM Investment Advisors
California
$231K – – –
AWM
50
AE Wealth Management
Kansas
$221K -$15.3K -208 -6%
1
2
3 4

PPH Hedge Fund Activity: Q3 2022 in Review

86 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q3 2022, worth a combined $416M — up 20% from $346M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of PPH and 8 opened new positions — a net loss of 5 holders — while 24 trimmed existing stakes and 30 added.

The largest buyer was Goldman Sachs, adding an estimated $128M. The largest seller was Morgan Stanley, cutting an estimated $6.13M.

  • 86 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q3 2022, down from 91 in Q2 2022.
  • Funds reported $416M of VanEck Pharmaceutical ETF stock for Q3 2022, up 20% quarter-over-quarter.
  • 8 funds opened new VanEck Pharmaceutical ETF positions in Q3 2022 and 13 closed out, a net change of -5 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q3 2022 was Goldman Sachs, an estimated $128M added.
  • The largest VanEck Pharmaceutical ETF seller in Q3 2022 was Morgan Stanley, an estimated $6.13M sold.

Based on aggregated 13F filings for Q3 2022.